扫描二维码，直接登录
题库 / Prep2007E2-CR-54
The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary.
Which of the following, if true, most strongly supports the pharmaceutical industry's argument against the challenge made above?
No industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on patent protection.
Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete.
There are several industries in which the ratio of research and development costs to revenues is higher than it is in the pharmaceutical industry.
An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug.
Much recent industrial innovation has occurred in products—example, in the computer and electronics industries—which patent protection is often very ineffective.
P：制药业表明如果没有更高收益、新药品的发明无法继续；而其他产业的新发明仍在继续
C：需要延长专利期限
——————类比推理——————
A：“除了制药业，没有其他产业要求延长专利期限”，无关选项，‘该不该延长’ 和‘多少人要求延长’无关
B：指出制药业的不同，“新药品在获得专利之后、推出药品销售之前，需要花费十年”
C：相反，“有几个产业的研发成本与收入之比 ＞ 制药业”，研发成本更高的产业都继续研发新产品了，说明制药业不应该要求延长专利期限
D：相反，说明专利权没用处，那么延长专利期限也没有意义。“现在的专利权每个软用，盗版药仍肆无忌惮”
E：无关选项，重复前提。“很多产业创新发生在专利权没有软用的产品上”
登录 或 注册 后可以参加讨论